Source link : https://newshealth.biz/health-news/dual-immunotherapy-and-liver-perfusion-delays-progression-in-uveal-melanoma/
(MedPage Today) — Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly reduced the risk of disease progression or death in metastatic uveal melanoma, a single… Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/120183 Author : Publish date : 2026-03-07 15:00:00 Copyright for syndicated content belongs to the linked Source.
The post Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-07 15:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8